Prof. Abdel-Razeq is the chairman of the Department of Internal Medicine, the Chief Medical Officer, and the Deputy Director General of the King Hussein Cancer Center in Amman, Jordan. Additionally, he was appointed as a professor of medicine at the School of Medicine of the University of Jordan. He obtained his medical degree from the University of Jordan in 1988 and took post-graduate training at the Cleveland Clinic Foundation and at the New York Medical College.
Prof. Abdel-Razeq holds American Board certifications in Internal Medicine, Medical Oncology, and Hematology. In addition to breast cancer and cancer genetics, Prof. Abdel-Razeq has major interests and research in cancer-related thrombosis. He has received many national and international awards, including “The King Hussein Cancer Research Award” in 2021.
Prof. Abdel-Razeq is the chairman of the Department of Internal Medicine, the Chief Medical Officer, and the Deputy Director General of the King Hussein Cancer Center in Amman, Jordan. Additionally, he was appointed as a professor of medicine at the School of Medicine of the University of Jordan. He obtained his medical degree from the University of Jordan in 1988 and took post-graduate training at the Cleveland Clinic Foundation and at the New York Medical College.
Prof. Abdel-Razeq holds American Board certifications in Internal Medicine, Medical Oncology, and Hematology. In addition to breast cancer and cancer genetics, Prof. Abdel-Razeq has major interests and research in cancer-related thrombosis. He has received many national and international awards, including “The King Hussein Cancer Research Award” in 2021.